Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

11

Revenue 2017

AstraZeneca

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of AstraZeneca's 2013 sales performance.

Astra Zeneca

AstraZeneca reduces initial COVID-19 vaccine deliveries to the EU

AstraZeneca reduces initial COVID-19 vaccine deliveries to the EU

Deliveries in the first quarter have been cut by 60%. AstraZeneca (AZ) has notified the EU that it will reduce initial deliveries of its Oxford-partnered COVID-19 vaccine by 60%

Pfizer/BioNTech reach vaccine supply agreement with COVAX

Pfizer/BioNTech reach vaccine supply agreement with COVAX This includes a deal with AstraZeneca (AZ) for 170 million doses of its Oxford University-partnered vaccine, as well as a ‘memorandum of understanding’ with Johnson &Johnson (J&J) for 500

Merck ends its COVID-19 vaccine programme after disappointing early trial results

Merck ends its COVID-19 vaccine programme after disappointing early trial results The COVID-19 vaccines from  Pfizer/BioNTech and Moderna have yielded efficacy rates above 90% –  coming in at 95% and 94.5%, respectively, with AstraZeneca/Oxford University’s COVID-19 vaccine

In plain sight

In plain sight Every volunteer in the global Pfizer, Moderna, AstraZeneca and J&J trials.

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post The company then suffered another major blow earlier this year when poor late-stage trial results for an antidepressant candidate abruptly brought about the end of its collaboration with AstraZeneca. .

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
dna Communications

Healthcare communications with unique thinking, insight and attitude...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics